242 related articles for article (PubMed ID: 24135855)
1. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
Nygren P; Fryknäs M; Agerup B; Larsson R
J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning.
Aliabadi A; Haghshenas MR; Kiani R; Koohi-Hosseinabadi O; Purkhosrow A; Pirsalami F; Panjehshahin MR; Erfani N
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2379-2388. PubMed ID: 37837472
[TBL] [Abstract][Full Text] [Related]
3. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Blom K; Senkowski W; Jarvius M; Berglund M; Rubin J; Lenhammar L; Parrow V; Andersson C; Loskog A; Fryknäs M; Nygren P; Larsson R
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):199-210. PubMed ID: 28472897
[TBL] [Abstract][Full Text] [Related]
4. Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways.
Huang L; Zhao L; Zhang J; He F; Wang H; Liu Q; Shi D; Ni N; Wagstaff W; Chen C; Reid RR; Haydon RC; Luu HH; Shen L; He TC; Tang L
Aging (Albany NY); 2021 Jul; 13(13):17407-17427. PubMed ID: 34232919
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose.
de la Torre-Iglesias PM; García-Rodriguez JJ; Torrado G; Torrado S; Torrado-Santiago S; Bolás-Fernández F
Drug Des Devel Ther; 2014; 8():1467-79. PubMed ID: 25258515
[TBL] [Abstract][Full Text] [Related]
6. Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer.
Nygren P; Larsson R
Acta Oncol; 2014 Mar; 53(3):427-8. PubMed ID: 24160353
[No Abstract] [Full Text] [Related]
7. Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
Králová V; Hanušová V; Staňková P; Knoppová K; Čáňová K; Skálová L
Anticancer Drugs; 2013 Oct; 24(9):911-9. PubMed ID: 23884106
[TBL] [Abstract][Full Text] [Related]
8. Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death.
Petersen JSSM; Baird SK
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2945-2953. PubMed ID: 34148157
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiparasitic activity of albendazole and mebendazole analogues.
Navarrete-Vázquez G; Yépez L; Hernández-Campos A; Tapia A; Hernández-Luis F; Cedillo R; González J; Martínez-Fernández A; Martínez-Grueiro M; Castillo R
Bioorg Med Chem; 2003 Oct; 11(21):4615-22. PubMed ID: 14527558
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Physicochemical Characterization and In Vitro and In Vivo Activity Against Heligmosomoides polygyrus of Novel Oral Formulations of Albendazole and Mebendazole.
Buchter V; Priotti J; Leonardi D; Lamas MC; Keiser J
J Pharm Sci; 2020 May; 109(5):1819-1826. PubMed ID: 32070702
[TBL] [Abstract][Full Text] [Related]
11. EFFECT OF THE ANTIPARASITIC DRUG MEBENDAZOLE ON CHOLANGIOCARCINOMA GROWTH.
Sawanyawisuth K; Williamson T; Wongkham S; Riggins GJ
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1264-70. PubMed ID: 26466412
[TBL] [Abstract][Full Text] [Related]
12. Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
Andersson CR; Selvin T; Blom K; Rubin J; Berglund M; Jarvius M; Lenhammar L; Parrow V; Loskog A; Fryknäs M; Nygren P; Larsson R
Sci Rep; 2020 Aug; 10(1):13124. PubMed ID: 32753665
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway.
Mizuno K; Toyoda Y; Fukami T; Nakajima M; Yokoi T
Arch Toxicol; 2011 Mar; 85(3):199-207. PubMed ID: 20848085
[TBL] [Abstract][Full Text] [Related]
14. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity.
Elmaaty AA; Darwish KM; Chrouda A; Boseila AA; Tantawy MA; Elhady SS; Shaik AB; Mustafa M; Al-Karmalawy AA
ACS Omega; 2022 Jan; 7(1):875-899. PubMed ID: 35036753
[TBL] [Abstract][Full Text] [Related]
15. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta.
McCracken RO; Lipkowitz KB; Dronen NO
Parasitol Res; 1992; 78(2):108-11. PubMed ID: 1557321
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of albendazole and mebendazole-induced, time-dependent oxidative stress.
Locatelli C; Pedrosa RC; De Bem AF; Creczynski-Pasa TB; Cordova CA; Wilhelm-Filho D
Redox Rep; 2004; 9(2):89-95. PubMed ID: 15231063
[TBL] [Abstract][Full Text] [Related]
18. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
[TBL] [Abstract][Full Text] [Related]
19. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
Bai RY; Staedtke V; Rudin CM; Bunz F; Riggins GJ
Neuro Oncol; 2015 Apr; 17(4):545-54. PubMed ID: 25253417
[TBL] [Abstract][Full Text] [Related]
20. Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness.
Joe NS; Godet I; Milki N; Ain NUI; Oza HH; Riggins GJ; Gilkes DM
Breast Cancer Res; 2022 Dec; 24(1):98. PubMed ID: 36578038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
